Homeacute migraine

  • Impel Neuropharma to present acute migraine treatment drug data at AHS 2018

    • June 28, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Strong clinical data with single dose rimegepant in acute treatment of migraine announced by Biohaven

    • April 24, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Biohaven to present additional Phase 3 Rimegepant Data at AAN 2018

    • April 20, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Migraine associated with Increased Heart stroke risk, says recent analysis

    • April 6, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • NDA filing of Acute Migraine Treatment by Dr. Reddy’s Laboratories and Promius Pharma

    • April 2, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Acute Migraine treatment Rimegepant successfully achieves Co-Primary Endpoints in two pivotal Phase 3 Trials

    • March 26, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Low risk of serotonin syndrome associated with concomitant use of triptans and SSRIs or SNRIs, finds latest study

    • March 24, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Acute Migraine treatment ZYDIS® ODT enrolls first patient in Ph 3 clinical trial

    • March 21, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more